• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Goldman initiated coverage on Shoulder Innovations with a new price target

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care
    Get the next $SI alert in real time by email
    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00
    Get the next $SI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SI

    DatePrice TargetRatingAnalyst
    8/25/2025$20.00Buy
    Goldman
    8/25/2025$23.00Buy
    BTIG Research
    8/25/2025$18.00Overweight
    Piper Sandler
    8/25/2025$19.00Buy
    Jefferies
    3/6/2023Neutral → Sell
    Compass Point
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    3/2/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gilde Healthcare Holding B.V. converted options into 2,280,482 shares and bought $1,500,000 worth of shares (100,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 6:37:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard was granted 7,666 shares and bought $75,000 worth of shares (5,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Pardo Geoffrey B converted options into 2,280,482 shares, bought $1,500,000 worth of shares (100,000 units at $15.00) and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:11 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoulder Innovations Reports Second Quarter 2025 Financial Results

    Company to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference Today at 8:30 a.m. ET GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights Increased net revenue 33% year-over-year to $11.0 million in the second quarter of 2025, in-line with the r

    9/9/25 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

    Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea

    8/28/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

    NEW YORK, July 31, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on July 31st Equities are catching a bid early Thursday after decent earnings reports from tech giants Microsoft and Meta. Apple and Amazon report their earnings after today's market close.Figma, which provides browser-based design software, raised $1.2 billion after pricing nearly 37 million shares at $33 each. The price was above an upwardly revised range and valued Figma at more than $19

    7/31/25 8:55:00 AM ET
    $ICE
    $SI
    Investment Bankers/Brokers/Service
    Finance
    Medical/Dental Instruments
    Health Care

    $SI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gilde Healthcare Holding B.V. converted options into 2,280,482 shares and bought $1,500,000 worth of shares (100,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 6:37:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buckman Paul converted options into 6,198 shares and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard was granted 7,666 shares and bought $75,000 worth of shares (5,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    SEC Filings

    View All

    SEC Form 10-Q filed by Shoulder Innovations Inc.

    10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    9/9/25 4:12:03 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    9/9/25 7:10:43 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Shoulder Innovations Inc.

    SCHEDULE 13G - SHOULDER INNOVATIONS, INC. (0001699350) (Subject)

    9/8/25 11:46:15 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Shoulder Innovations with a new price target

    Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Shoulder Innovations with a new price target

    BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Leadership Updates

    Live Leadership Updates

    View All

    Silvergate announces changes to its executive team

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod

    11/7/22 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Mary-Margaret Henke to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial

    9/19/22 4:15:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Rebecca Rettig to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Rebecca Rettig to the board of directors for both the Company and its subsidiary bank, Silvergate Bank. "I am honored to join Silvergate's board at this moment of evolution in the bank's history and the digital asset ecosystem," said Rebecca Rettig. "I look forward to working with Silvergate's leadership and my fellow board members to strengthen the Company's leadership position in this evolving and innovative industry." "Rebecca's broad wealth of knowledge in the blockchain and

    3/16/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Financials

    Live finance-specific insights

    View All

    Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

    Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea

    8/28/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Suspends Series A Preferred Stock Dividend

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th

    1/27/23 6:55:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Fourth Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Commentary During the fourth quarter of 2022, the digital asset industry experienced a transformational shift, with significant over-leverage in the industry leading to several high-profile bankruptcies. These dynamics created a crisis of confidence across the ecosystem and led many industry participants to shift to a "risk off" position across digital asset trading platforms. In turn, the Company saw significant outflows of deposits during the quarter a

    1/17/23 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    5/22/23 4:03:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 4:49:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care